OakChart

Alignment Healthcare Inc

ALHCHealthcare·Healthcare Plans·USA·Small·NASD·Nov 11 • 2:09 PM ET

7.73+0.06 (0.77%)
2026-11-11 20:09 CET
Market cap
1,605.09 USD m
Revenue, TTM
4,941.92 USD m
Net income, TTM
28.92 USD m
Free cash flow, TTM
77.04 USD m
EPS diluted, TTM
0.13
P/E
59.36
Compare

Price

ALHC against its 20, 50 and 200-day averages
2050200beatearnings
5.0010.0015.0020.0025.0015.6M31.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ALHCclose 7.7320-day 7.8950-day 8.91200-day 16.197.7352w high52w low

69.2% under the 52-week high of 25.12 on 7 Jul 2026. 52-week low 6.01 on 9 Oct 2026. Last 15 sessions, 23.9% high to low

Profile

ALHC
52-week range, 9% of the way up
6.0125.12

Alignment Healthcare, Inc. is a holding company, which offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. It offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered in Orange, CA.

IndexRUT
Employees1849
IPOMar 26, 2021
Beta1.03
ATR, 14d0.55
Rel volume0.25
Short float11.57%
Insider own4.36%
Inst own113.20%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.62B
Enterprise Value-
Income28.92M
Sales4.94B
Book/sh1.32
Cash/sh-
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1849
IPOMar 26, 2021

Ratios

P/E59.36
Forward P/E47.52
PEG-
P/S0.33
P/B5.83
P/C-
P/FCF21.00
EV/EBITDA-
EV/Sales-
Quick Ratio-
Current Ratio1.71
Debt/Eq1.19
LT Debt/Eq1.19
Option/ShortYes / Yes

Earnings

EPS (ttm)0.13
EPS next Y0.16
EPS next Q-0.22
EPS this Y-
EPS next Y616.66%
EPS next 5Y-
EPS past 3/5Y83.51% 50.33%
Sales past 3/5Y40.16% 32.71%
EPS Y/Y TTM224.33%
Sales Y/Y TTM35.87%
EPS Q/Q-316.85%
Sales Q/Q36.69%
EarningsOct 29 AMC
EPS/Sales Surpr.-9.89% 3.51%

Ownership

Insider Own4.36%
Insider Trans-20.27%
Inst Own113.20%
Inst Trans7.32%
ROA2.41%
ROE13.17%
ROIC4.76%
Gross Margin-
Oper. Margin0.88%
Profit Margin0.59%
SMA20-2.05%
SMA50-13.24%
SMA200-52.26%
Trades-

Technical

Shs Outstand209.15M
Shs Float200.14M
Short Float11.57%
Short Ratio2.87
Short Interest23.15M
52W High25.12 -69.23%
52W Low6.01 28.61%
Volatility8.61% 6.16%
ATR (14)0.55
RSI (14)44.93
Beta1.03
Rel Volume0.25
Avg Volume8.08M
Volume1,455,786

Performance

Perf Week-5.05%
Perf Month-6.88%
Perf Quarter-42.58%
Perf Half Y-57.69%
Perf YTD-60.86%
Perf Year-53.10%
Perf 3Y28.82%
Perf 5Y-65.62%
Perf 10Y-
Recom1.94
Target Price10.79
Prev Close7.67
Price7.73
Change %0.77%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 30, 2026DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight
Oct 28, 2026InitiatedNNeedhamHold
Oct 09, 2026DowngradeWWilliam BlairOutperform → Mkt Perform
Aug 03, 2026DowngradeRRaymond JamesStrong Buy → Outperform$19+145.8%
Apr 17, 2026InitiatedWWolfe ResearchOutperform$24+210.5%
Nov 24, 2025UpgradeJJP MorganNeutral → Overweight$20+158.8%
Oct 14, 2025InitiatedGGoldmanBuy$21+171.7%
Aug 25, 2025UpgradeKKeyBanc Capital MarketsSector Weight → Overweight$21+171.7%
Jul 31, 2025UpgradeBBarclaysUnderweight → Equal Weight$13+68.2%
Dec 03, 2024UpgradeSStephensEqual-Weight → Overweight$13 → $17+119.9%

Peers

Mkt cap
TickerCompanyMkt cap
CLOVClover Health Investments Corp2.64B
HUMHumana Inc53.85B
UNHUnitedhealth Group Inc358.21B
CVSCVS Health Corp113.48B
ELVElevance Health Inc92.00B
ASTHAstrana Health Inc1.63B
CNCCentene Corp34.88B
MOHMolina Healthcare Inc10.87B
OSCROscar Health Inc10.08B
AGLAgilon Health Inc1.93B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Joseph KonowieckiChairman / EVP, Corporate AffaNov 10 '26Proposed Sale7.275,50039,985Nov 09 05:57 PM
Kim HyongChief Medical OfficerOct 06 '26Sale8.3032,479269,576299,271Oct 07 04:00 PM
Hyong (Ken) Kim, M.D.Chief Medical OfficerOct 06 '26Proposed Sale8.4836,000305,280Oct 05 05:14 PM
KONOWIECKI JOSEPH SEVP, Corporate AffairsSep 17 '26Sale8.6123,511202,4301,080,305Sep 18 04:29 PM
KAO JOHN EChief Executive OfficerSep 14 '26Sale13.0027,400356,200590,766Sep 16 05:57 PM
Joseph KonowieckiDirector / EVP, Corporate AffaSep 17 '26Proposed Sale8.7126,000226,460Sep 16 05:52 PM
Maroney Dawn ChristinePresidentSep 11 '26Sale12.68122,7071,555,925794,606Sep 11 08:41 PM
KAO JOHN EChief Executive OfficerSep 11 '26Sale12.68385,2704,885,2241,223,473Sep 11 08:38 PM
KAO JOHN EChief Executive OfficerSep 10 '26Sale12.96172,6002,236,447618,166Sep 11 08:38 PM
JEK TRUST U/A DTD 02/08/2021DirectorSep 10 '26Proposed Sale13.03500,0006,515,000Sep 10 04:37 PM
Dawn C. MaroneyPresidentSep 10 '26Proposed Sale13.06130,0001,697,800Sep 09 06:00 PM
John KaoChief Executive Officer / DireSep 10 '26Proposed Sale13.06405,0005,289,300Sep 09 05:57 PM
Maroney Dawn ChristinePresidentAug 14 '26Sale14.005,00070,000917,313Aug 18 04:01 PM
DAWN MARONEYOfficerAug 14 '26Proposed Sale13.465,00067,300Aug 14 04:34 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IJTiShares S&P Small-Cap 600 Growth ETFAUM: 7.45B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 200
  • Survey Suggests a Simple Beverage Swap Can Inspire Healthier Habits Among Seniors (GlobeNewswire) +5.50%
  • Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSS (PR Newswire) -9.80%
  • Alignment Healthcare Matches EPS Forecast, But A Medical-Cost Surge Forces A Steep Profit Reset Despite Accelerating Growth (Earnings Whispers)
  • Alignment Healthcare: Q3 Earnings Snapshot (Associated Press)
  • Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook (GlobeNewswire)
  • Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors (GlobeNewswire)
  • Alignment Healthcare's Planned Third-Quarter Dip Meets A Stock That Has Lost Nearly Half Its Value (Earnings Whispers)
  • Alignment Health Expands Medicare Advantage Plan to Nye County for 2027 (GlobeNewswire)
  • Alignment Health Plan Recognized Among U.S. News & World Report's 2027 Best Insurance Companies for Medicare Advantage (GlobeNewswire)
  • Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors (GlobeNewswire)
  • Alignment Health Expands Medicare Advantage Coverage to San Antonio for 2027 (GlobeNewswire)
  • Alignment Healthcare to Announce Third Quarter 2026 Financial Results and Host Conference Call Thursday, Oct. 29, 2026 (GlobeNewswire)
  • ALHC: Alignment Healthcare Investors Should Contact Block & Leviton to Possibly Recover Losses (Newsfile)
  • Alignment sues CMS over 2027 Medicare Advantage star ratings crash (Healthcare Dive)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-29-0.040-0.036-0.0401,3581,31212
2026Q22026-07-300.1700.1290.1701,3361,31011
2026Q12026-04-300.0500.0070.0541,2351,21811
2025Q42026-02-26-0.050-0.154-0.0551,0131,00310
2025Q32025-10-300.020-0.0810.018993.7981.3410
2025Q22025-07-300.070-0.0720.0751,015960.519
2025Q12025-05-01-0.050-0.127-0.047926.93888.238
2024Q42025-02-27-0.160-0.186-0.162701.24676.799
2024Q32024-10-29-0.140-0.110-0.138692.43669.7912
2024Q22024-08-01-0.130-0.143-0.126681.29637.668
2024Q12024-05-02-0.250-0.228-0.246628.6599.759
2023Q42024-02-27-0.250-0.227-0.251465.39444.568
2023Q32023-11-02-0.190-0.184-0.187456.71443.458
2023Q22023-08-03-0.150-0.183-0.153462.38438.9710
2023Q12023-05-04-0.200-0.255-0.204439.16431.347
2022Q42023-02-28-0.310-0.297-0.312361.81341.17

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-0.135--0.122959.29-
2021FY-1.140-1.003-1.1361,1681,140
2022FY-0.830-0.796-0.8251,4341,413
2023FY-0.790-0.656-0.7951,8241,802
2024FY-0.670-0.683-0.6712,7042,679
2025FY0.000-0.1020.0003,9493,939
2026FY--0.032--5,260
2027FY-0.163--6,574
2028FY-0.124--7,720
2029FY-0.815--10,051
2030FY-1.300--12,210

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-3012341,3341,3161,381
2026Q4S2026-10-2912101,3341,3191,360
2026Q4S2026-10-2712101,3341,3191,360
2026Q4S2026-10-2011101,3341,3191,360
2026Q4S2026-10-1411101,3341,3191,360
2026Q4S2026-10-0511301,3341,3191,360
2026Q4S2026-09-1411201,3321,3191,343
2026Q4S2026-08-1411201,3321,3191,343
2026Q4S2026-08-0311201,3321,3191,343
2026Q4S2026-07-3111201,3311,3191,343
2026Q4S2026-07-2811001,3281,3151,333
2026Q4S2026-07-2611001,3281,3151,333
2026Q4S2026-07-2112001,3301,3151,351
2026Q4S2026-07-1512011,3301,3151,351

Estimate history

EPS, annual-0.239-0.122-1.136-0.825-0.795-0.671-0.0040.1302
Period2019202020212022202320242025TTM
EPS, quarterly-0.138-0.162-0.0470.0750.018-0.0550.0540.17-0.039
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual756.961959.2221167.7731434.1591823.632703.5613948.7194941.92
Period2019202020212022202320242025TTM
Sales, quarterly692.433701.241926.9321015.288993.6951012.8041235.1971335.6331358.29
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual187.274187.274187.194187.28188.952191.779204.154209.152
Period2019202020212022202320242025MRQ
Shares, quarterly191.596191.779197.668197.958199.989204.154206.671207.178209.152
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue4,941.923,948.722,703.561,823.631,434.161,167.77959.22756.96
Losses, Claims & Reserves4,352.493,460.162,406.871,622.601,249.881,039.04792.99661.39
Selling, General and Administrative Incl. Other545.91473.81398.25328.85312.92306.80171.49125.06
Operating Income before Interest Expense43.5214.75-101.56-127.82-128.64-178.07-5.26-29.48
Interest Expense16.5715.8023.5521.2318.2917.4416.9314.90
Unusual Expense-0.003.020.002.20---
Net Income Before Taxes26.96-0.96-128.05-148.19-149.30-195.29-22.93-44.73
Income Taxes-1.960.020.02-0.020.340.000.000.00
Consolidated Net Income28.92-0.98-128.07-148.17-149.64-195.29-22.93-44.73
Net Income From Continuing Operations28.92-0.72-128.03-148.02-149.55-195.29-22.93-44.73
Net Income28.92-0.72-128.03-148.02-149.55-195.29-22.93-44.73
EPS (Recurring)0.14-0.00-0.66-0.79-0.82-1.14-0.12-0.24
EPS (Basic, Before Extraordinaries)0.14-0.00-0.67-0.79-0.83-1.14-0.12-0.24
EPS (Diluted)0.13-0.00-0.67-0.79-0.83-1.14-0.12-0.24
Non-Operating Income (Expense)0.000.090.070.85-0.180.23-0.73-0.35
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense49.6149.0456.1952.8064.56122.002.121.16
Price To Earnings Ratio58.9158.91------
Price To Sales Ratio0.340.990.790.881.492.07--
Operating Margin0.880.37-3.76-7.01-8.97-15.25-0.55-3.90
Net Margin0.59-0.02-4.74-8.12-10.43-16.72-2.39-5.91
Shares Outstanding209.15204.15191.78188.95187.28187.19187.27187.27
Market Capitalization1,605.091,605.092,156.581,628.152,202.192,632.752,630.88-
Operating Income after Interest Expense--1.05-125.10-149.05-146.93-195.51-22.19-44.38
Reserves Increase (Decrease)-0.000.000.000.000.000.000.00

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,358.291,335.631,235.201,012.80993.701,015.29926.93701.24
Losses, Claims & Reserves1,217.601,154.681,090.72889.49868.02881.74820.90614.90
Selling, General and Administrative Incl. Other144.48138.86128.98133.59117.99110.80111.42108.89
Operating Income before Interest Expense-3.7942.1015.50-10.287.6822.75-5.39-22.55
Interest Expense4.284.284.063.953.953.953.955.49
Operating Income after Interest Expense-8.0737.8311.44-14.233.7318.80-9.34-28.04
Unusual Expense---0.00---3.02
Net Income Before Taxes-8.0737.8311.44-14.233.7318.88-9.33-31.06
Income Taxes-0.021.270.03-3.230.003.220.020.01
Consolidated Net Income-8.0536.5611.42-11.013.7315.65-9.35-31.06
Net Income From Continuing Operations-8.0536.5611.42-11.013.7315.67-9.11-31.09
Net Income-8.0536.5611.42-11.013.7315.67-9.11-31.09
EPS (Recurring)-0.040.170.05-0.050.020.07-0.05-0.15
EPS (Basic, Before Extraordinaries)-0.040.180.06-0.050.020.08-0.05-0.16
EPS (Diluted)-0.040.170.05-0.050.020.07-0.05-0.16
Non-Operating Income (Expense)0.000.000.000.000.000.080.010.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense13.8114.3611.0810.3612.8212.2913.5812.83
Price To Earnings Ratio58.91260.50------
Price To Sales Ratio0.341.120.881.011.000.881.200.80
Operating Margin-0.283.151.26-1.020.772.24-0.58-3.22
Net Margin-0.592.740.92-1.090.381.54-0.98-4.43
Shares Outstanding209.15207.18206.67204.15199.99197.96197.67191.78
Market Capitalization1,605.094,922.343,599.713,951.823,455.642,769.803,571.912,156.58

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Cash577.94434.94204.95411.30468.35207.3186.48
Investments28.4137.79115.910.000.000.000.00
Premium Balance Receivables - Insurance253.21153.90119.7592.8958.5140.1435.63
Net Property, Plant & Equipment71.2774.9661.8642.9938.2137.0327.44
Investment in Unconsolidated Affiliates0.000.000.000.000.000.000.00
Other Intangible Assets134.9680.4789.4086.6865.8254.0243.88
Total Assets1,065.79782.06591.88633.86630.89338.50193.44
Insurance Policy Liabilities - Insurance474.57289.79205.40170.13125.89112.61102.38
Total Debt338.07338.31181.48172.50168.28168.06137.96
Long Term Debt336.11337.10179.76168.30164.57164.71137.96
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities73.8753.0146.9351.9330.6827.2331.81
Total Liabilities886.51681.11433.81394.56324.84307.89272.15
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00
Common Equity179.2899.85156.95238.13306.0430.61-78.71
Total Shareholders Equity179.2899.85156.95238.13306.0430.61-78.71
Accumulated Minority Interest0.001.101.121.180.010.000.00
Total Equity179.28100.95158.07239.30306.0630.61-78.71
Total Liabilities & Stockholders Equity1,065.79782.06591.88633.86630.89338.50193.44
Book Value Per Share0.880.520.831.271.630.16-0.42
Tangible Book Value Per Share0.700.320.621.061.45-0.02-0.61
Full-Time Employees1,8491,6791,5361,037847775-
Price to Book Ratio5.7918.828.638.098.608.09-
Return on Assets-0.08-18.64-24.15-23.65-40.29-8.62-
Return on Equity-0.52-99.72-74.93-54.96-116.02--
Return on Invested Capital-0.14-29.30-43.96-36.80-41.50-11.74-75.50
Current Ratio1.711.881.842.373.311.720.98

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Funds from Operations127.7394.42-26.12-61.21-39.87-59.364.31-19.79
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-19.7145.5160.892.03-5.55-19.423.2529.00
Cash from Operating Activities108.02139.9334.77-59.19-45.43-78.787.569.21
Capital Expenditures-30.98-26.78-41.42-35.99-23.77-18.36-15.71-10.24
Net Assets From Acquisitions0.000.000.000.00-4.14-1.410.000.00
Sale of Fixed Assets and Businesses0.001.140.030.100.070.010.100.00
Purchase or Sale of Investments11.4910.6780.59-111.27-0.40-1.05-0.750.01
Purchase of Investments-52.95-65.63-82.20-379.06-2.83-2.48-1.57-0.32
Sale Or Maturity of Investments64.4476.30162.79267.792.421.430.820.33
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-19.49-14.9739.21-147.16-28.25-20.80-16.36-10.24
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock23.5318.070.000.000.00360.12130.12-1.48
Repurchase of Common Pref Stock0.000.000.000.000.00-1.47-4.88-1.98
Sale of Common Pref Stock23.5318.070.000.000.00361.59135.000.50
Proceedsfrom Stock Options5.460.000.000.000.00361.59135.000.50
Issuance or Reduction of Debt, Net0.000.00156.210.0016.620.000.0054.15
Change in Long Term Debt0.000.00156.210.0016.620.000.0054.15
Issuance of Long Term Debt0.000.00371.210.00159.800.000.0054.15
Reduction of Long Term Debt0.000.00-215.000.00-143.180.000.000.00
Net Financing Active Other Cash Flow0.000.00-0.200.000.000.000.000.00
Other Financing Activities Uses-2.40-0.03-0.200.00-5.200.000.00-0.85
Cash from Financing Activities21.1318.04156.010.0016.62360.12130.1252.66
Net Change in Cash109.66142.99229.99-206.34-57.05260.54121.3351.63
Free Cash Flow77.04113.15-6.65-95.18-69.20-97.14-8.15-1.04
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Price to Free Cash Flow22.0934.56------

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Total Cash729.84695.591,411.17577.94620.18472.36
Investments16.298.2620.7128.4126.0133.51
Net Property, Plant & Equipment73.6473.5270.9471.2774.3677.10
Investment in Unconsolidated Affiliates0.000.000.000.000.000.00
Other Intangible Assets234.54204.78-518.88134.96162.23134.25
Total Assets1,296.861,279.041,261.611,065.791,102.611,000.15
Insurance Policy Liabilities - Insurance621.75612.75655.97474.57528.80455.15
Total Debt330.70330.50329.97338.07329.66329.66
Long Term Debt330.70330.50329.97336.11329.66329.66
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities67.3170.6668.7973.8782.2974.37
Total Liabilities1,019.751,013.911,054.72886.51940.74859.18
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity277.11265.13206.88179.28161.87140.97
Total Shareholders Equity277.11265.13206.88179.28161.87140.97
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity277.11265.13206.88179.28161.87140.97
Total Liabilities & Stockholders Equity1,296.861,279.041,261.611,065.791,102.611,000.15
Book Value Per Share1.321.281.000.880.810.71
Tangible Book Value Per Share1.151.100.820.700.630.53
Full-Time Employees---1,849--
Price to Book Ratio5.7923.7920.0624.4024.5025.59
Return on Assets2.413.571.84-0.08-2.32-5.94
Return on Equity13.1720.0412.57-0.52-15.06-38.50
Return on Invested Capital-1.326.142.13-2.140.763.33
Current Ratio1.711.701.581.711.611.66

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Funds from Operations19.0163.8734.0110.8429.2938.36
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital28.02-81.1894.67-61.22115.27-9.23
Cash from Operating Activities47.03-17.31128.68-50.38144.5629.13
Capital Expenditures-8.44-10.14-7.36-5.03-5.50-8.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.001.14
Purchase or Sale of Investments-6.8812.567.94-2.137.810.20
Purchase of Investments-15.68-6.24-10.60-20.44-10.19-17.10
Sale Or Maturity of Investments8.7918.8018.5418.3018.0017.30
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-15.322.420.58-7.162.31-6.66
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock2.553.512.1715.300.951.62
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock2.553.512.1715.300.951.62
Proceedsfrom Stock Options2.553.512.17-2.770.951.62
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.00-0.74-1.660.000.000.00
Cash from Financing Activities2.552.770.5215.300.951.62
Net Change in Cash34.25-12.12129.78-42.24147.8224.08
Free Cash Flow38.58-27.46121.32-55.40139.0621.13
Price to Free Cash Flow22.0928.8416.6135.0824.22103.26

Revenue breakdown

Total Hospital & Medical Service Plans revenue2024: 2.70B 2025: 3.95B
United States2024: 2.70B 2025: 3.95B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.57%23.1M200.1M8.53M
2026-10-1512.86%25.5M198.4M8.15M
2026-09-3011.90%23.6M198.4M7.13M
2026-09-1512.41%24.6M198.3M5.48M
2026-08-3111.56%22.8M197.6M5.70M
2026-08-1411.91%23.5M197.6M5.71M
2026-07-3111.22%22.0M196.5M6.20M
2026-07-1512.67%24.8M195.9M5.95M
2026-06-3012.46%24.4M195.6M5.67M
2026-06-1513.01%25.4M195.4M5.29M
2026-05-2913.03%25.4M195.2M4.49M
2026-05-1512.85%25.1M195.2M4.36M
2026-04-308.86%16.1M182.0M3.13M
2026-04-159.43%17.0M179.8M3.14M
2026-03-319.18%16.4M178.3M2.97M
2026-03-138.92%15.9M178.3M2.91M
2026-02-278.93%15.9M178.3M2.73M
2026-02-139.19%16.1M174.6M2.75M
2026-01-309.31%16.2M174.2M2.81M
2026-01-159.93%17.3M174.2M2.59M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.005.507.400.0019.3860.000.000.990-0.0140.000
call2.504.605.8011.008.5851.000.000.979-0.0150.001
call4.002.454.300.005.5300.000.000.965-0.0140.001
call5.002.003.302.684.13523.000.000.951-0.0130.001
call6.000.452.100.002.4140.000.000.927-0.0120.002
call7.500.400.550.400.9138842.000.603-0.0270.005
call9.000.000.200.141.2513740.000.246-0.0270.004
call10.000.000.050.051.12813,9295.000.086-0.0120.002
call11.000.000.050.051.67614.000.000.113-0.0220.002
call12.500.000.050.042.0766,1730.000.096-0.0240.002
call14.000.000.950.002.1280.000.000.052-0.0150.001
call15.000.000.750.012.3154,2840.000.049-0.0160.001
call16.000.001.000.002.4860.000.000.046-0.0160.001
call17.500.000.750.362.7123,6630.000.043-0.0170.001
call20.000.000.050.052.9295,4150.000.040-0.0160.001
call22.500.000.050.403.2031,4520.000.037-0.0170.001
call25.000.000.050.603.44328.000.000.035-0.0170.001
call30.000.000.050.803.84731.000.000.032-0.0180.001
call35.000.000.050.054.17811.000.000.031-0.0190.001
put1.000.000.050.007.2300.000.00-0.010-0.0130.000
put2.500.000.750.004.2240.000.00-0.021-0.0140.001
put4.000.000.750.002.6040.000.00-0.035-0.0130.001
put5.000.000.750.011.8331340.00-0.049-0.0120.001
put6.000.000.050.052.15050.000.00-0.179-0.0380.003
put7.500.200.400.321.0598735.00-0.397-0.0260.005
put9.001.051.700.991.77810.000.00-0.754-0.0260.004
put10.002.002.702.202.2531480.00-0.915-0.0110.002
put11.003.003.603.292.4120.003.00-0.929-0.0120.002
put12.503.505.404.743.74081.001.00-0.941-0.0130.001
put14.005.007.100.004.5840.000.00-0.948-0.0140.001
put15.006.008.106.504.87950.000.00-0.951-0.0140.001
put16.007.009.100.005.0980.000.00-0.954-0.0150.001
put17.508.6010.609.405.4191140.00-0.957-0.0150.001
put20.0011.1013.503.006.80950.000.00-0.960-0.0150.001
put22.5013.6016.003.657.2010.000.00-0.963-0.0160.001
put25.0016.1018.5011.907.5470.000.00-0.965-0.0160.001
put30.0021.0023.500.008.0830.000.00-0.968-0.0160.001
put35.0026.0028.500.008.5510.000.00-0.970-0.0160.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13G/ASEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-05SCHEDULE 13G/ASEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-088-KCurrent report2026-10-08SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-05SCHEDULE 13G/ASEC
2026-10-05144Filing for proposed sale of securities under Rule 144.SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-16144Filing for proposed sale of securities under Rule 144.SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-09-09144Filing for proposed sale of securities under Rule 144.SEC
2026-09-09144Filing for proposed sale of securities under Rule 144.SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-14144Filing for proposed sale of securities under Rule 144.SEC
2026-08-13SCHEDULE 13GSEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-07-31SCHEDULE 13GSEC
2026-07-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-308-KCurrent report2026-07-30SEC
2026-07-27SCHEDULE 13G/ASEC
2026-07-164Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-15144Filing for proposed sale of securities under Rule 144.SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-10144Filing for proposed sale of securities under Rule 144.SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1000269.58K1
2026-09009.24M5
2026-08004.21M2
2026-070010.21M3
2026-06197.63K19.02M6
2026-05005.52M2
2026-040012.60M6
2026-030011.32M15
2026-02004.76M3
2026-010011.91M6
2025-1200438.11M12
2025-11003.49M3

Institutional holders

Manager% owned
BlackRock, Inc.9.36%
WELLINGTON MANAGEMENT GROUP LLP9.08%
T. Rowe Price Investment Management, Inc.6.35%
VANGUARD PORTFOLIO MANAGEMENT LLC5.65%
Invesco Ltd.5.01%
BANK OF AMERICA CORP /DE/4.52%
FMR LLC4.19%
VANGUARD CAPITAL MANAGEMENT LLC3.94%
STATE STREET CORP3.53%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC3.01%

Funds

Fund% owned
SMALLCAP World Fund Inc3.58%
VANGUARD HEALTH CARE FUND3.35%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.85%
iShares Russell 2000 ETF2.22%
VANGUARD SMALL-CAP INDEX FUND2.06%
T. Rowe Price Small-Cap Stock Fund, Inc.2.01%
Hood River Small-Cap Growth Fund1.97%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.19%
Virtus Convertible & Income Fund1.13%
T. Rowe Price Institutional Small-Cap Stock Fund1.10%

OakChart. ALHC. Cached 15 minutes.